Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Rucaparib maintenance and monotherapy for ovarian cancer: trial updates

Jonathan Ledermann • 27 Sep 2019
ESMO 2019
Gynecological Cancer Ovarian Cancer Rucaparib
ARIEL2 ARIEL3 Study 10

Speaking from the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain, Jonathan Ledermann, MD, FRCP, University College London, London, UK, discusses the use of rucaparib for both maintenance and monotherapy treatment in patients with ovarian cancer, highlighting the ARIEL3 trial (NCT01968213), ARIEL2 trial (NCT01891344) and Study 10 (NCT01482715). Here, Prof. Ledermann talks about the safety and tolerability of this PARP inhibitor in ovarian cancer.

More from Jonathan Ledermann

Trametinib: new treatment for recurrent LGSOC
1:59
Trametinib: new treatment for recurrent LGSOC
Jonathan Ledermann • 27 Sep 2019
The potential of PARP inhibitors in ovarian cancer: PAOLA-1, PRIMA & VELIA
3:58
The potential of PARP inhibitors in ovarian cancer: PAOLA-1, PRIMA & VELIA
Jonathan Ledermann • 28 Oct 2019
Rucaparib maintenance for recurrent ovarian carcinoma
2:09
Rucaparib maintenance for recurrent ovarian carcinoma
Jonathan Ledermann • 30 Sep 2019
ICON8: Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer
3:27
ICON8: Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer
Jonathan Ledermann • 11 Sep 2017

Related Videos

The future of antibody-drug conjugates in endometrial cancer
1:10
The future of antibody-drug conjugates in endometrial cancer
Linda Mileshkin • 30 May 2026
B7-H4-directed ADC in endometrial versus ovarian cancer
0:43
B7-H4-directed ADC in endometrial versus ovarian cancer
Linda Mileshkin • 30 May 2026
Barriers to cervical cancer screening among rural women in India
0:54
Barriers to cervical cancer screening among rural women in India
Shailendra Dandge • 31 May 2026
A community-based model for cervical cancer screening uptake in rural India
8:39
A community-based model for cervical cancer screening uptake in rural India
Shailendra Dandge • 31 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals